Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli

Nasopharyngeal Carcinoma Post IMRT

NCT02597426 ·Status: ACTIVE_NOT_RECRUITING

TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer

NCT00765011 ·Status: COMPLETED ·Phase: PHASE2

Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT05527782 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention

NCT06821243 ·Status: RECRUITING

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life

NCT06136962 ·Status: NOT_YET_RECRUITING

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

NCT05494190 ·Status: RECRUITING ·Phase: NA

Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma

NCT05151588 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

NCT05628922 ·Status: RECRUITING ·Phase: PHASE2

H&N Cancer; Survivorship and Late Effects

NCT04758026 ·Status: COMPLETED

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

NCT01312311 ·Status: UNKNOWN ·Phase: PHASE2

Single Modality Trans Oral Robotic Surgery for Primary Oropharyngeal Cancer: Exploring the Impact of Surgical Margins on Local Disease Recurrence

NCT05065086 ·Status: UNKNOWN

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

NCT00565448 ·Status: COMPLETED ·Phase: PHASE2

NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)

NCT00916097 ·Status: COMPLETED ·Phase: PHASE2

Human Papillomavirus and Oropharynx Carcinoma

NCT00918710 ·Status: UNKNOWN

The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma

NCT02916368 ·Status: UNKNOWN

Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma

NCT05328024 ·Status: RECRUITING

Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer

NCT01645748 ·Status: COMPLETED ·Phase: PHASE2

Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT00623558 ·Status: COMPLETED ·Phase: PHASE2

Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer

NCT03894891 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab

NCT00941135 ·Status: TERMINATED ·Phase: PHASE2

Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer

NCT04825990 ·Status: RECRUITING ·Phase: PHASE2

The Impact of Multimodality Treatment on Physical Functions and Quality of Life in Patients With Head and Neck Cancer

NCT05036902 ·Status: COMPLETED

Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma

NCT02984410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00402545 ·Status: COMPLETED ·Phase: PHASE1

Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma

NCT00169182 ·Status: COMPLETED ·Phase: PHASE3